a developer of proprietary, potentially curative therapeutics
Industry Biotechnology
A.I.dvisor indicates that over the last year, NTLA has been closely correlated with BEAM. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then BEAM could also see price increases.
Ticker / NAME | Correlation To NTLA | 1D Price Change % | ||
---|---|---|---|---|
NTLA | 100% | -3.65% | ||
BEAM - NTLA | 74% Closely correlated | -8.55% | ||
EDIT - NTLA | 74% Closely correlated | -6.68% | ||
CRSP - NTLA | 71% Closely correlated | -4.61% | ||
PRME - NTLA | 66% Closely correlated | -9.81% | ||
DNLI - NTLA | 65% Loosely correlated | +2.78% | ||
More |
Ticker / NAME | Correlation To NTLA | 1D Price Change % |
---|---|---|
NTLA | 100% | -3.65% |
NTLA (5 stocks) | 87% Closely correlated | +0.13% |
biotechnology (248 stocks) | 70% Closely correlated | +5.56% |
drugs (265 stocks) | 68% Closely correlated | +5.37% |
therapeutics (57 stocks) | 56% Loosely correlated | +20.54% |